Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

Affiliations

¹ Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. Stephanie.Nahas@jefferson.edu.
² Department of Neurology, University Hospital Halle (Saale) and University Halle-Wittenberg, Halle, Germany.
³ Teva Pharmaceutical Industries, West Chester, PA, USA.
⁴ Department of Neurology and Westgerman Headache Center Essen, University Hospital, Essen, Germany.
⁵ California Medical Clinic for Headache, Santa Monica, CA, USA.
⁶ Headache Medical Centre, Linz, Austria.
⁷ Department of Neurology, Konventhospital Barmherzige Brüder, Linz, Austria.

Published Erratum

Stephanie J Nahas et al. J Headache Pain. 2022.

. 2022 May 17;23(1):57.

doi: 10.1186/s10194-022-01423-x.

¹ Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. Stephanie.Nahas@jefferson.edu.
² Department of Neurology, University Hospital Halle (Saale) and University Halle-Wittenberg, Halle, Germany.
³ Teva Pharmaceutical Industries, West Chester, PA, USA.
⁴ Department of Neurology and Westgerman Headache Center Essen, University Hospital, Essen, Germany.
⁵ California Medical Clinic for Headache, Santa Monica, CA, USA.
⁶ Headache Medical Centre, Linz, Austria.
⁷ Department of Neurology, Konventhospital Barmherzige Brüder, Linz, Austria.

No abstract available

Erratum for

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
Nahas SJ, Naegel S, Cohen JM, Ning X, Janka L, Campos VR, Krasenbaum LJ, Holle-Lee D, Kudrow D, Lampl C. Nahas SJ, et al. J Headache Pain. 2021 Nov 24;22(1):141. doi: 10.1186/s10194-021-01351-2. J Headache Pain. 2021. PMID: 34819017 Free PMC article. Clinical Trial.

1. Nahas, et al. Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies. J Headache Pain. 2021;22:141. doi: 10.1186/s10194-021-01351-2. - DOI - PMC - PubMed